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Abstract
Background: It is very rare that gastrointestinal stromal tumor (GIST) occurs in the sacrum. Only
one case of GIST occuring in the sacral region, with intracranial metastasis, has been reported in
the literature. Moreover, only few cases have been published in literature about its clonal origin.
Case presentation: In this report, we present a rare case of GIST occuring in the sacrum and
describe its clinicopathologic features, c-KIT gene mutation and clonal status. Microscopically, the
lesion was composed of spindle cells arranged in cords, knitted and whirlpool patterns. Trabecula
of bone were found in the lesion. The cytoplasm of tumor cells were abundant, and the nuclei were
fusiform. Mitotic figures were rare. Immunohistochemically, the tumor cells showed positive
reactivity for CD117 and CD34. On mutation analysis, a c-KIT gene mutation was found in exon
11. The result of clonal analysis demonstrated that the GIST was monoclonal.
Conclusion: In summary, we showed that tumor material, phenotypically identical with GISTs was
found in the sacrum. It is difficult to differentiate GISTs from other spindle cell tumors, hence the
need for immunohistochemistry, the examination of c-KIT gene amplification and sequencing.
Background
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal tumors of the gastrointestinal
tract. They are supposed to arise from the Cajal's cells
expressing c-KIT [1]. This type of tumor is considered to be
a gastrointestinal tract primary, non-epithelial, non-lym-
phatic, non-smooth muscle and non-schwannoma neo-
plasm. Its most common anatomic sites of origin are the
stomach (60–70%), small intestine (20–30%), colon and
rectum (5%), abdominal cavity, peritoneum and omen-
tum (5%), esophagus (<5%) and the retroperitoneal
space (<3%) [2-4]. However, it is very rare that GISTs
occur in sacrum. Only one case of GIST of the sacral
region with intracranial metastasis has been reported in
the literature [5].
In this report we present a rare case of GIST occuring in the
sacrum, describing and discussing its histopathological
characteristic and c-KIT gene mutation as an aid for the
pathologist. We suggest that GIST should be considered
when a spindle cells tumor with atypical immunological
phenotype occurs in the bone. In addition, the examina-
tion of c-KIT gene amplification and sequencing should
be carried out to further confirm its diagnosis.
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Case presentation and Methods
Case presentation
A 50-year-old female patient with the history of lower left
limb pain and dyschesia for three months was admitted to
the department of Bone, Tangdu Hospital, the Fourth Mil-
itary Medical University, Xi'an, ShaanXi Province, China.
There was no history of swelling, anesthesia, limitation of
activity, hemafecia or crissum pain. A computed tomogra-
phy (CT) scan of the abdoman and pelvis demonstrated a
small (2 × 1.5 × 0.8 cm) low-density, well circumscribed
mass in the sacrum, without evidence of tumor infiltra-
tion of adjacent structures(Figure. 1). Then, a resection
was carried out. Written informed consent was obtained
from the patient and the protocol was approved by the
Institutional Ethics Committee of the Fourth Military
Medical University based on the Helsinki Declaration.
Methods
Immunohistochemistry
Immunohistochemical staining was carried out using a
streptavidin-labeled peroxidase (S-P) kit (KIT9730)
according to the manufacturer's instructions. The primary
antibodies used in this study included those against
CD34, Desmin, neuronal specific enolase (NSE), nerve
fiber (NF), placental alkaline phosphatase (PLAP) and
glial fibrillary acidic protein (GFAP) for mouse anti-
human monoclonal antibodies (mAb), and CD117, S-
100 protein, smooth muscle actin (SM-actin), SC-actin,
and to exclude melanoma HMB45 for rabbit anti-human
polyclonal antibodies, as well as vimentin for mouse anti-
pig mAb. All of the reagents for immunostaining were
supplied by Maxim Biotechnology Corporation Limited,
Fuzhou, China.
Microdissection and DNA extraction
Eight 10 μm sections from formalin-fixed, paraffin
embedded tissue samples were used for DNA extraction.
After H/E staining, the sections were covered with 100%
glycerol. Lesions in the sections were dissected using a
syringe needle under an inverted microscope after observ-
ing their histological appearance. Tissue samples were col-
lected in 100% ethanol in 1.5-mL tubes. For each
dissected neoplasm, the surrounding fibrous connective
tissue (with the same surface area) was also isolated and
analyzed as a control. Collected samples were dehydrated
three times with 100% ethanol and then dried at room
temperature. Genomic DNA was extracted using a
QIAamp Kit (Qiagen, Mannheim, Germany) according to
the manufacturer's instructions.
c-KIT mutation analysis
Exons 9, 11, 13 and 17 of the c-KIT gene were evaluated
for the presence of mutations by PCR amplification and
direct sequencing. The primer pairs used for PCR amplifi-
cation and direct sequencing are given in Table 1. Briefly,
the PCR reaction was carried out in a final volume of 50
μl, under the following conditions: 4 μL of 10 mM dNTP
(Gibco BRL, Life Technologies, Inc., Gaithersburg, MD,
USA), forward and reverse primers (0.4 pmol each), 5 μL
of 10× buffer, 1.5 μL of 50 mM MgCl2 and 2.5 U of Taq
DNA polymerase (Gibco BRL). The amplification was
conducted using a PT-200 thermocycler (MJ Research,
Inc., Watertown, MA, USA) for 35 cycles (95°C for 30 sec,
56°C or 60°C for 40 sec, and 72°C for 30 sec). Amplifica-
tion products were separated by 2% agarose ethidium
bromide gel electrophoresis to confirm correct amplifica-
tion. Then, direct sequencing was performed; the results
showed no mutation in exon 9, 13 and 17 expect for exon
11. Thus, the PCR products for exon 11 was ligated to the
pGEM-T plasmid vector, the recombinant vector was
transformed into E. coli DH5alpha, and the positive
clones were selected by blue/white screening. Restriction
enzyme digestion with EcoR I and BamH I, gel electro-
phoresis analysis, followed by sequencing of the digested
product were performed for identification of the recom-
binant product. The informative plasmid was then sent to
Shanghai Biotechnology Co. Ltd., for purification and
sequencing.
PCR amplification for clonal assay
Nested PCR was used for amplification and detection of
single nucleotide polymorphism (SNP) sites in the phos-
phoglycerate kinase (PGK) and the length polymorphism
of CAG short-tandem repeat (STR) in exon 1 of the andro-
gen receptor (AR) gene loci, two pairs of primers to
amplify the PGK gene were used: PGK1A, 5'-CTG TTC
CTG CCC GCG CGG TGT TCC GCA TTC-3'; PGK1B, 5'-
ACG CCT GTT ACG TAA GCT CTG CAG GCC TCC-3';
PGK2A, 5'-AGC TGG ACG TTA AAG GGA AGC GGG TCG
TTA-3'; PGK2B, 5'-TAC TCC TGA AGT TAA ATC AAC ATC
CTC TTG-3'. The genomic DNA extracts from lesions and
surrounding tissue, 10 μL each, were incubated with 5 U
of Hpa II (Promega, Madison, WI, USA) at 37°C for 3 h in
a volume of 20 μL containing 0.2 μL of 10 g/L bovine
serum albumin (BSA) and 2 μL of 10× reaction buffer. The
Computed tomography (CT) scan of the abdomen and plevis  demonstrated a small (2 × 1.5 × 0.8 cm) low-density, well cir- cumscribed mass in the sacrum, without evidence of tumor  infitration of adjacent structures (three different CT-slice, A,  B, and C) Figure 1
Computed tomography (CT) scan of the abdomen 
and plevis demonstrated a small (2 × 1.5 × 0.8 cm) 
low-density, well circumscribed mass in the sacrum, 
without evidence of tumor infitration of adjacent 
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digested DNA samples, 5 μL each, were then subjected to
nested PCR. The reaction mixture was 50 μL in volume,
containing 4 μL of 10 mM dNTP (Gibco BRL, Life Tech-
nologies, Inc., Gaithersburg, MD, USA), primers PGK1A
and PGK1B (0.4 pmol each), 5 μL of 10× buffer, 1.5 μL of
50 mM MgCl2 and 2.5U of Taq DNA polymerase (Gibco
BRL). The amplification was conducted using a PT-200
thermocycler (MJ Research, Inc., Watertown, MA, USA)
for 35 cycles (94°C for 40 sec, 58°C for 50 sec, and 72°C
for 1 min). The first round of PCR products (5 μL) were
diluted (1:20) and used as templates for a second PCR
reaction using the primers PGK2A and PGK2B. The ampli-
fication procedure was the same as for the first round,
except that the annealing temperature was 56°C. The PCR
products were digested with 5 U Bst XI at 48°C for 8–10 h
in a 20 μL mixture containing 0.2 μL of 10 g/L BSA and 2
μL of 10× reaction buffer. The digested products were
resolved in 2% (g/mL) agarose gel containing ethidium
bromide (0.2 mg/L).
For the AR gene, two pairs of primers and amplication
condition were used according to the previous described
[6]. The amplification efficiency was checked by resolving
PCR reaction aliquots on 2% agarose gels. The PCR prod-
ucts, 4 μL for each, were also mixed with the same volume
of loading buffer (1 g/L xylene cyanole, 1 g/L bromophe-
nol blue, in formamide), and resolved on an 8% polyacr-
ylamide gel containing 8 mol/L urea using the Mini-VE
system (Amersham Biosciences, San Francisco, CA, USA)
at 120 V for 4 h. Bands were visualized using silver stain-
ing.
Analysis and assessment of PCR products
Images of PCR gels were recorded and the intensities of
the PCR bands for both alleles were quantitated using an
image-analyzing system (LabWorks 3.0, UVP, Cambridge,
UK). A reduction in fluorescence intensity of at least 50%
for either band, as compared to the intensity of the bands
obtained in the absence of Hpa II or Hha I digestion, were
used as indicators of a loss of X chromosome inactivation
mosaicism [7]. A corrected ratio (CR) was calculated by
dividing the ratio of the upper-band intensity to the
lower-band intensity, or vice versa, of the same sample
before and after digestion to give a CR value >1. In the
present study, a CR value ≥ 2 was used to define a loss of
X chromosome inactivation mosaicism.
Results
Pathological observation
The resected irregular tissue was 4.0 cm × 2.5 cm × 0.5 cm
in size, the cut surface being grayish-white and the texture
being moderate. Microscopically, the lesion was com-
posed of spindle cells arranged in cords, knitted and
whirlpool patterns. Trabecula of bone were found in the
lesion (Figure 2A, 2B). The cytoplasm of tumor cells were
abundant, and the nuclei were fusiform. Evidence of
mitosis was not readily apparent. The tumor tissues
showed a positive reaction for CD117 (Figure 3A), CD34
(Figure 3B) and vimentin, but not for desmin, PLAP, S-
100, SM-actin, NF, GFAP, NSE, HMB-45, and SC-actin.
The amplification and detection of mutation of exons 9, 
11, 13, 17 of the c-KIT gene
The amplification efficiency for exon 9, 11, 13 and 17 of
the c-KIT gene were checked by resolving PCR reaction
aliquots on 2% agarose gels. Bands were observed at 283
bp, 227 bp, 193 bp and 228 bp, respectively (Figure 4),
which further confirmed the diagnosis of GIST. Moreover,
Table 1: c-KIT gene oligonucleotide primer
c-KIT exon sequence (5'-3') length of PCR product
(bp)
annealing temperature
(°C)
9 (F) 5'-TCC TAG AGT AAG CCA GGG CTT T-3' 283 56
9 (R) 5'-TGG TAG ACA GAG CCT AAA CAT CC-3'
11 (F) 5'-CTG AGA CAA TAA TTA TTA AAA GGT GA-3' 227 60
11 (R) 5'-TTA TGT GTA CCC AAA AAG GTG ACA-3'
13 (F) 5'-GCT TGA CAT CAG TTT GCC AG-3' 193 60
13 (R) 5'-AAA GGC AGC TTG GAC ACG GCT TTA-3'
17 (F) 5'-TAC AAG TTA AAA TGA ATT TAA ATG GT-3' 228 56
17 (R) 5'-AAG TTG AAA CTA AAA ATC CTT TGC-3'
Microscopically, the lesion was composed of spindle cells  arranged in cords, knit and whirlpool patterns Figure 2
Microscopically, the lesion was composed of spindle 
cells arranged in cords, knit and whirlpool patterns. 
Trabecula of bone was found in them (2A, 2B Original magni-
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mutations of exons 9, 11, 13 and 17 of the c-KIT gene were
examined according to the PCR methods. The result dem-
onstrated that the c-KIT gene mutation was only found in
exon 11, namely the deletion of 15 bp (CTC AAC AAC
CTT CCA) was found at position 100(Figure 5), but not in
the following domains (exon 9, 13 and 17).
Clonality determination
The clonality assay demonstrated their polymorphism for
the samples at PGK and AR loci. On the PGK and AR PCR
gel pictures, DNA samples of the tissue analysed without
Hpa II or Hha  I digestion showed two bands of equal
intensity. when DNA samples of the lesions were digested
with Hpa II or Hha I, the upper bands exhibited an obvi-
ously reduced intensity or had disappeared (Figure 6A,
6B). Monoclonality was demonstrated for the lesions,
suggesting that they were neoplastic lesions. However, the
intensities of the two bands were equal for the surround-
ing fibrous connective tissue treated with or without Hpa
II or Hha I. The results indicate that GIST is a neoplastic
lesion.
Discussion and Conclusion
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal tumors of the gastrointestinal
tract with an incidence of 10–20 cases per million of
which almost one third are deemed malignant [8]. The
usual age at presentation is around 60 years, and this
tumor is predominantly seen in Caucasians with little
gender difference. GIST may present anywhere in the gas-
trointestinal tract, omentum, or mesentery. The most
common sites are the stomach (60%), small intestine
(15%), colon and rectum (5%), other abdominal organs
including mesentery and omentum (5%) [9]. However, it
is very rare that GIST occurs in the sacrum.
The diagnosis of GISTs mostly relies on histopathological
features and the immunohistochemical phenotype, and
the most important immunohistochemical feature is the
positivity of the tumor cells for CD117 and CD34. It has
been reported in the literature that 90–95% of GISTs
express CD117, 60–70% express CD34, 30–40% SM-actin
and only 5% are positive for S-100 protein [10]. GIST
could be differentiated from other mesenchymal tumors,
such as schwannoma or leiomyoma, according to its dis-
tinct immunohistochemical characteristics. Based on his-
topathological observation and immunohistochemical
staining in the current case, the tumor cells were found
positive for CD117 and CD34 and showed typical mor-
phological characteristics. Moreover, the results of PCR
amplification and detection of mutation of the c-KIT gene
showed that the c-KIT gene mutation occurred in exon 11,
but not in other domains investigated (exon 9, 13 and
17), in support of a diagnosis of GIST in this case. How-
ever, it must be differentiated from germ cells tumors
from female, such as dysgerminoma of the ovary and
mixed germ cell tumors. Because their tumor cells are not
only positive for CD117 [11], but also there has been
reported a frequent presence of KIT mutations in them
[12]. But it is different that a typical dysgerminoma com-
ponent has uniform individual tumor cells. These show
the usual microscopic findings, which are round nuclei
with granular chromatin, distinct nucleoli, clear to finely
granular cytoplasm containing abundant glycogen and
distinct cell borders. In addition, lymphocytes (most of
which are of T-cell type) may be found in stromal fibrous
strands. Immunohistochemically, the tumor cells are pos-
itive for PLAP and CD117, but negative for CD34. The
above of characteristics are different from that of GIST.
Thus, the diagnosis of GIST is reliable.
However, the results of our analysis did not identify the
tumor as being primary or secondary. When a GIST occurs
in bone, it should immediately be suspected as being a
metastatic or invasive lesion from the gastrointestinal
tract. In the current study, after the diagnosis of GIST was
made, a series of examinations, including computerized
tomographic (CT) scanning and magnetic resonance
imaging (MRI) on liver, cholecyst, pancreas, spleen, kid-
The tumor cells were positive for CD117 (3A, Original mag- nification 200×) and CD34 (3B, Original magnification 200×) Figure 3
The tumor cells were positive for CD117 (3A, Origi-
nal magnification 200×) and CD34 (3B, Original mag-
nification 200×).
The results of 2% agarose gels showed that there was a band  at 283 bp, 227 bp, 193 bp and 228 bp, respectively Figure 4
The results of 2% agarose gels showed that there was 
a band at 283 bp, 227 bp, 193 bp and 228 bp, respec-
tively.BMC Gastroenterology 2009, 9:43 http://www.biomedcentral.com/1471-230X/9/43
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ney and ovary, and especially an electronic endoscopy on
digestive tract, were performed on the patient, but no
lesion was found. The question then becomes whether the
original lesion had disappeared or this GIST had occurred
primarily in the bone. The possibility of primary origin
was worth investigating further.
Monoclonality is one of the main features of most tumors,
whereas normal and reactive hyperplastic lesions are pol-
yclonal [13]. The clonality assay is based on X-chromo-
some inactivation mosaicism and polymorphism at the
PGK and AR loci in female somatic cells. There are two X
chromosomes within each female somatic cell, one of
which is inactivated randomly by methylation during
early embryogenesis, while the other preserves its genetic
activity throughout life [14]. PGK gene polymorphism
showed there was a single nucleotide polymorphic site
identified by Bst XI located downstream of the methyla-
tion site [15]. AR polymorphism shows different lengths
of the CAG short-tandem repeat (STR) at exon 1 [16].
After digestion with the methylation-sensitive restriction
enzymes Hpa II or Hha I, the normal and reactive hyper-
plastic tissues with polymorphism showed two alleles
with equal intensity. Neoplastic tissues showed only one,
or one of two alleles with obviously reduced intensity
[17].
GIST has been considered as a mesenchymal tumor in
recent years. Only few studies have been reported in the
literature about its clonal origin [18,19]. In our analysis of
the clonal status of a case of multiple GISTs occurring in
the peritoneum, GIST appeared to be monoclonal, and 15
different tumor nodules showed loss of the identical X
chromosomal inactivation mosaicism. This indicated a
common clonal origin for the tumors [20]. The results of
the clonal assay for the current case were similar to those
previously described, thus, confirming further the neo-
plastic nature of the GIST examined in this study.
Abbreviations
AR: androgen receptor; GIST: gastrointestinal stromal
tumor; CT: computed tomography; SNP: single nucle-
otide polymorphism; PGK: phosphoglycerate kinase; STR:
short-tandem repeat; CR: corrected ratio.
The result of DNA sequencing demonstrated that the c-kit gene mutation was only found in exon 11, namely the deletion of 15  bp (CTC AAC AAC CTT CCA) was found at position 100 bp Figure 5
The result of DNA sequencing demonstrated that the c-kit gene mutation was only found in exon 11, namely 
the deletion of 15 bp (CTC AAC AAC CTT CCA) was found at position 100 bp.
When the DNA samples of the lesion tissue were digested  with Hpa II or Hha I Figure 6
When the DNA samples of the lesion tissue were 
digested with Hpa II or Hha I. a) the upper bands exhib-
ited an obviously reduced intensity or disappeared for PGK 
gene loci. -, pretreated without Hpa II; +, pretreated with 
Hpa II; M, DNA marker. b) the upper bands exhibited an 
obviously reduced intensity or disappeared for AR gene loci. 
-, pretreated without Hha I; +, pretreated with Hha I; M, 
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